• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PTEN 表达改变;鉴别正常、增生和肿瘤性子宫内膜的诊断标志物。

Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium.

机构信息

Department of Pathology, Mirza Koochak Khan Hospital, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Diagn Pathol. 2009 Nov 25;4:41. doi: 10.1186/1746-1596-4-41.

DOI:10.1186/1746-1596-4-41
PMID:19930726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2789036/
Abstract

BACKGROUND

Different molecular alterations have been described in endometrioid endometrial carcinoma (EECA). Among them the most frequently altered is loss of the PTEN protein, a tumor suppressor gene. The purpose of this study was to evaluate the expression pattern of PTEN gene in normal, hyperplastic and neoplastic endometrium.

METHODS

In a study in a referral gynecologic hospital in Tehran, Iran, immunohistochemical (IHC) evaluation of PTEN was performed on 87 consecutive specimens to the following three groups; group A- normal proliferative endometrium(n = 29); group B- hyperplastic endometrium [including simple hyperplasia without atypia(n = 21) and complex hyperplasia with atypia (n = 8)] and group C- EECA(n = 29). Immunostaining of cells was analyzed by arbitrary quantitative methods according to both slide's area staining and intensity of color reaction.

RESULTS

PTEN immunoreactivity was present in all normal proliferative endometrium, all simple hyperplasia, 75% of atypical complex hyperplasia and in 48% of EECA (P < 0.001). The intensity of PTEN reaction was significantly higher in group with proliferative endometrium than hyperplastic endometrium and EECA (P < 0.001).

CONCLUSION

PTEN expression was significantly higher in cyclical endometrium than in atypical hyperplasia and endometrioid carcinoma.

摘要

背景

子宫内膜样腺癌(EECA)存在不同的分子改变。其中最常见的改变是抑癌基因 PTEN 蛋白的缺失。本研究旨在评估 PTEN 基因在正常、增生和肿瘤性子宫内膜中的表达模式。

方法

在伊朗德黑兰一家转诊妇科医院进行的一项研究中,对 87 例连续标本进行了免疫组织化学(IHC)评估,将其分为三组:A 组-正常增生性子宫内膜(n=29);B 组-增生性子宫内膜[包括单纯非典型增生(n=21)和复杂非典型增生(n=8)];C 组-EECA(n=29)。根据玻片的区域染色和颜色反应强度,采用任意定量方法分析细胞免疫染色。

结果

PTEN 免疫反应性存在于所有正常增生性子宫内膜、所有单纯性增生、75%的非典型复杂性增生和 48%的 EECA 中(P<0.001)。在增殖性子宫内膜组中,PTEN 反应的强度明显高于增生性子宫内膜组和 EECA 组(P<0.001)。

结论

PTEN 表达在周期性子宫内膜中明显高于非典型增生和子宫内膜样癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/2789036/104b64a815d2/1746-1596-4-41-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/2789036/f88fd6896da2/1746-1596-4-41-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/2789036/1a3a4705725a/1746-1596-4-41-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/2789036/8950e7401331/1746-1596-4-41-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/2789036/104b64a815d2/1746-1596-4-41-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/2789036/f88fd6896da2/1746-1596-4-41-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/2789036/1a3a4705725a/1746-1596-4-41-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/2789036/8950e7401331/1746-1596-4-41-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6884/2789036/104b64a815d2/1746-1596-4-41-4.jpg

相似文献

1
Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium.PTEN 表达改变;鉴别正常、增生和肿瘤性子宫内膜的诊断标志物。
Diagn Pathol. 2009 Nov 25;4:41. doi: 10.1186/1746-1596-4-41.
2
Alteration of the k-ras gene expression in atypical and nonatypical hyperplastic endometrium.非典型与非非典型增生性子宫内膜中k-ras基因表达的改变
Iran J Cancer Prev. 2013 Fall;6(4):209-13.
3
Differential Expression Patterns of PTEN in Cyclic, Hyperplastic and Malignant Endometrium: Its Relation with ER, PR and Clinicopathological Parameters.PTEN在周期性、增生性及恶性子宫内膜中的差异表达模式:其与雌激素受体、孕激素受体及临床病理参数的关系
J Egypt Natl Canc Inst. 2009 Dec;21(4):323-31.
4
Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.视网膜母细胞瘤相关基因Rb2/p130在非典型子宫内膜增生和腺癌中的表达下调。
Hum Pathol. 2001 Apr;32(4):360-7. doi: 10.1053/hupa.2001.23514.
5
Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.正常、增生性和肿瘤性子宫内膜中c-myc、c-jun和雌激素受体的免疫组织化学分析
Pathol Oncol Res. 2005;11(1):32-9. doi: 10.1007/BF03032403. Epub 2005 Mar 31.
6
Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.子宫内膜增生和腺癌中PTEN免疫反应性的检测。
J Med Assoc Thai. 2008 Aug;91(8):1161-5.
7
Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.细胞周期蛋白D1在正常、化生、增生性子宫内膜及子宫内膜样癌中的表达提示其在子宫内膜癌发生过程中发挥作用。
Arch Pathol Lab Med. 2002 Apr;126(4):459-63. doi: 10.5858/2002-126-0459-EOCDIN.
8
Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium.良性、增生性和恶性子宫内膜中p53及增殖细胞核抗原表达的计算机图像分析
Arch Pathol Lab Med. 2001 Jul;125(7):872-9. doi: 10.5858/2001-125-0872-CIAOPA.
9
Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.存活素、PTEN和p27在正常、增生性和癌性子宫内膜中的表达。
Int J Gynecol Cancer. 2006 May-Jun;16(3):1412-8. doi: 10.1111/j.1525-1438.2006.00541.x.
10
[Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].β-连环蛋白、葡萄糖转运蛋白1、磷酸酶和张力蛋白同源物蛋白在子宫内膜样腺癌及其前驱病变中的表达
Zhonghua Bing Li Xue Za Zhi. 2009 Sep;38(9):594-9.

引用本文的文献

1
EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.EXOSC5 通过调节 NTN4/整合素 β1 信号轴维持子宫内膜癌中的癌症干细胞活性。
Int J Biol Sci. 2024 Jan 1;20(1):265-279. doi: 10.7150/ijbs.86275. eCollection 2024.
2
Phosphatase and Tensin Homolog Immunohistochemical Expression and Promoter Methylation Status in Endometrioid Endometrial Carcinoma and Its Precursor Lesions.磷酸酶与张力蛋白同源物在子宫内膜样腺癌及其前驱病变中的免疫组化表达和启动子甲基化状态
Cureus. 2022 Oct 27;14(10):e30778. doi: 10.7759/cureus.30778. eCollection 2022 Oct.
3
Liquid Biopsy as a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations.

本文引用的文献

1
Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases.卵巢子宫内膜样腺癌的发病机制途径:29例分子研究
Am J Surg Pathol. 2009 Aug;33(8):1157-63. doi: 10.1097/PAS.0b013e3181a902e1.
2
Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.子宫内膜增生和腺癌中PTEN免疫反应性的检测。
J Med Assoc Thai. 2008 Aug;91(8):1161-5.
3
PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.子宫内膜活检中PTEN的表达作为子宫内膜癌进展的标志物。
液体活检作为甲状腺癌遗传和表观遗传改变的微创来源
Int J Mol Cell Med. 2019 Winter;8(Suppl1):19-29. doi: 10.22088/IJMCM.BUMS.8.2.19. Epub 2019 May 29.
4
Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors.液体活检:追踪实体瘤遗传学的独特检测方法。
Epigenet Insights. 2020 Feb 28;13:2516865720904052. doi: 10.1177/2516865720904052. eCollection 2020.
5
Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer That Is Associated with Poor Outcomes in Endometrial Carcinoma.表达:一种潜在的代谢生物标志物,可区分子宫内膜癌前病变和癌症,与子宫内膜癌不良预后相关。
Int J Environ Res Public Health. 2019 Nov 20;16(23):4589. doi: 10.3390/ijerph16234589.
6
Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma.人甲状腺乳头状癌中四个抑癌基因的启动子甲基化
Iran J Pathol. 2019 Fall;14(4):290-298. doi: 10.30699/ijp.2019.94401.1922. Epub 2019 Sep 22.
7
The Impact Of Gene (SDH) Mutations In Renal Cell Carcinoma (RCC): A Systematic Review.基因(SDH)突变在肾细胞癌(RCC)中的影响:一项系统综述。
Onco Targets Ther. 2019 Sep 26;12:7929-7940. doi: 10.2147/OTT.S207460. eCollection 2019.
8
Personalized treatment options for thyroid cancer: current perspectives.甲状腺癌的个性化治疗方案:当前观点
Pharmgenomics Pers Med. 2019 Sep 13;12:235-245. doi: 10.2147/PGPM.S181520. eCollection 2019.
9
Study of the Association of Phosphatase and Tensin Homolog and p27 Expressions in Endometrial Hyperplasia and Carcinoma.子宫内膜增生和癌中磷酸酶与张力蛋白同源物及p27表达的相关性研究
J Microsc Ultrastruct. 2019 Jul-Sep;7(3):109-116. doi: 10.4103/JMAU.JMAU_54_18.
10
The Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis.琥珀酸脱氢酶基因(SDHx)在肿瘤发生中的新作用。
Int J Hematol Oncol Stem Cell Res. 2019 Apr 1;13(2):72-82.
Cancer Res. 2008 Jul 15;68(14):6014-20. doi: 10.1158/0008-5472.CAN-08-1154.
4
Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A review.子宫内膜增生中的免疫组织化学标志物:是否存在有前景的标志物组合?综述
Appl Immunohistochem Mol Morphol. 2008 Jul;16(4):329-43. doi: 10.1097/PAI.0b013e318159b88e.
5
From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures.从子宫内膜增生到子宫内膜癌:对生物学及可能的医学预防措施的洞察
Eur J Cancer Prev. 2008 Apr;17(2):133-8. doi: 10.1097/CEJ.0b013e32811080ce.
6
The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study.PTEN、p53和β-连环蛋白在子宫内膜癌中的预后价值:一项前瞻性免疫细胞化学研究。
Int J Gynecol Cancer. 2007 May-Jun;17(3):697-704. doi: 10.1111/j.1525-1438.2007.00845.x.
7
Molecular carcinogenesis of endometrial cancer.子宫内膜癌的分子致癌机制
Taiwan J Obstet Gynecol. 2007 Mar;46(1):26-32. doi: 10.1016/S1028-4559(08)60102-3.
8
Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.PTEN在正常、增生性及恶性子宫内膜中的免疫组化表达及其与激素受体、bcl-2、bax和凋亡指数的相关性。
Pathol Res Pract. 2007;203(3):153-62. doi: 10.1016/j.prp.2007.01.003. Epub 2007 Feb 20.
9
PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.子宫内膜样腺癌和复杂性非典型增生中的PIK3CA和PTEN突变
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5932-5. doi: 10.1158/1078-0432.CCR-06-1375.
10
Molecular and pathologic aspects of endometrial carcinogenesis.子宫内膜癌发生的分子与病理学方面
J Clin Oncol. 2006 Oct 10;24(29):4783-91. doi: 10.1200/JCO.2006.06.7173.